Last reviewed · How we verify

NCT01509976

Triclosan, Triclocarban, and the Microbiota

Completed NA Last updated 17 March 2021
What this trial tests

NA trial testing triclosan/triclocarban-containing personal care products in Triclosan Effects on Microbial Flora in 20 participants. Completed in 31 December 2017.

Timeline
1 July 2011
Primary endpoint
1 October 2015
31 December 2017

Quick facts

Lead sponsorStanford University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposeother
Enrollment20
Start date1 July 2011
Primary completion1 October 2015
Estimated completion31 December 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

18 and older, any sex, with Triclosan Effects on Microbial Flora. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Triclosan (5-chloro-2 (22,4-dichlorophenoxy)phenol) is a broad-spectrum antibacterial and antifungal agent that is found in thousands of common household products, including deodorants, toothpaste, "antibacterial" soaps, cleaning products, kitchen utensils, bedding, socks, trash bags. The benefits of triclosan have not been proven except in reducing plaque and gingivitis when used in toothpaste. In this study, the investigators intend to look at whether exposure to triclosan changes the colonizing flora of the skin, gut and mouth as well as changes in certain blood hormone levels, including adipocytokines, androgens, and inflammatory markers. Changes in the gut microbiota have been associated with a variety of disease states such as inflammatory bowel disease, colorectal cancer. Additionally, reductions in the microbiome diversity have been associated with obesity.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract.
    Zhang J, Walker ME, Sanidad KZ, Zhang H, et al · · 2022 · cited 74× · PMID 35013263 · DOI 10.1038/s41467-021-27762-y
  2. Crossover Control Study of the Effect of Personal Care Products Containing Triclosan on the Microbiome.
    Poole AC, Pischel L, Ley C, Suh G, et al · · 2016 · cited 47× · PMID 27303746 · DOI 10.1128/msphere.00056-15
  3. Metabolic fate of environmental chemical triclocarban in colon tissues: roles of gut microbiota involved.
    Wang G, Zhang H, Zhang J, Sanidad KZ, et al · · 2021 · cited 15× · PMID 34004538 · DOI 10.1016/j.scitotenv.2021.147677
  4. Microbiota-mediated reactivation of triclosan oxidative metabolites in colon tissues.
    Zhang H, Sanidad KZ, Zhang J, Wang G, et al · · 2023 · cited 8× · PMID 36463744 · DOI 10.1016/j.jhazmat.2022.130509

Verify or expand the search:

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01509976.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing